Skip to content
Subscriber Only

Apollo, CVC Are Vying for Perrigo's Pharmaceuticals Unit

  • Division could fetch slightly more than $2.5 billion in sale
  • Carlyle, Altaris and Cerberus also bidding for Generix Rx
Perrigo to Buy Elan for $8.6 Billion to Get Irish Tax Base

Photographer: Andrew Harrer/Bloomberg

Apollo Global Management LLC and CVC Capital Partners are among bidders vying for Perrigo Co.’s prescription pharmaceuticals arm, according to people with the matter.

Carlyle Group LP, Altaris Capital Partners LLC and Cerberus Capital Management have also advanced to the next round of bidding for Perrigo’s Generic Rx unit, said the people, who asked to not be identified because the matter is private. The business could fetch slightly more than $2.5 billion, one of the people said.